Pfizer at Six Ten Main/MIT
Client: MIT Investment Management Company, Pfizer
- Designed for optimum flexibility, this 597,000-sf, two-building research and development campus provides new laboratories and offices for Pfizer and further enriches Kendall Square’s world-leading life science cluster.
- With a program that includes street-level retail, offices, and laboratory/research facilities, the campus also provides parking for 650 cars on three levels below-grade.
- Pfizer’s research facilities fill the seven-story South Building and most of the North Building, accommodating the company’s neuroscience, cardiovascular, metabolic, BTX, and endocrine disease research units.
- Other tenants include CRISPR Therapeutics, LabCentral, KSQ Therapeutics, Bayer LifeHub Boston, Casebia Therapeutics, and Pfizer’s Centers for Therapeutic Innovation.
Photographer: Chuck Choi